Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-23

FDA Approved: ALVIMOPAN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for ALVIMOPAN submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvimopan (alvimopan)

Snippet

SUPPL AP for ALVIMOPAN (ALVIMOPAN)